Popular Filters
Trials With No Placebo
Behavioral Intervention
Assessments for Delayed Sleep Phase Syndrome
This trial aims to investigate why some people have delayed sleep wake phase disorder (DSWPD). Researchers will study if individuals with DSWPD have changes in their biological clock and how they respond to light
Behavioral Intervention
Sleep Intervention for Teen Depression
This trial aims to test if improving the relationship between sleep patterns and waking time can help improve depression outcomes in teenagers with depression and disrupted sleep patterns. The trial will use a sleep intervention to target this issue
Behavioural Intervention
Timing of Cognitive Training for ICU Survivors' Cognitive Impairment
This trial will examine the optimal timing of cognitive interventions to improve cognitive function in older adults in ICU. It will compare a morning vs. late afternoon/evening session to standard care.
Frequently Asked Questions
Introduction to delayed sleep phase syndrome
What are the top hospitals conducting delayed sleep phase syndrome research?
When it comes to the cutting-edge clinical trials focused on delayed sleep phase syndrome (DSPS), several top hospitals are leading the way. The University of Michigan in Ann Arbor has taken an active role in addressing DSPS with one ongoing trial and a total of three studies dedicated to this condition. Their commitment to understanding this disorder began with their first recorded DSPS trial in 2019. Similarly, Washington University School of Medicine in Saint Louis is making strides with one active DSPS trial and two previously conducted studies since their inaugural trial in 2022.
Meanwhile, at the University of Virginia in Charlottesville, researchers are also actively investigating DSPS through one ongoing clinical trial and have contributed to the field with a total of one study thus far, initiated just recently in 2022. Stanford University located in Redwood City is another notable institution focusing on DSPS, currently conducting an active clinical trial while having completed a single study since embarking on their first investigation into the disorder also during 2022.
In addition to these renowned institutions, Western Psychiatric Hospital situated in Pittsburgh plays a significant role by engaging in vital research for those affected by DSPS. They currently have one active clinical trial underway and have already made important contributions through their sole previous study that was initiated back as early as 2021.
These hospitals collectively demonstrate dedication towards unraveling the mysteries surrounding delayed sleep phase syndrome—the condition characterized by individuals experiencing difficulties synchronizing their sleep-wake cycle with conventional societal norms. By investing efforts into understanding this disorder further via clinical trials, they aim to develop innovative solutions that will bring relief and improved quality of life for individuals grappling with disrupted sleep patterns caused by delayed sleep phase syndrome.
Which are the best cities for delayed sleep phase syndrome clinical trials?
When it comes to delayed sleep phase syndrome clinical trials, several cities are leading the way in research. Redwood City, California is currently conducting 2 active trials focusing on treatments like Lemborexant and Tasimelteon. Ann Arbor, Michigan; Saint Louis, Missouri; Charlottesville, Virginia; and Pittsburgh, Pennsylvania each have 1 active trial exploring different approaches such as Propofol total intravenous anesthesia (TIVA), melatonin group interventions, and monitoring sleep patterns along with mood and substance use. These cities offer individuals with delayed sleep phase syndrome access to ongoing clinical trials that aim to improve understanding of the condition and develop effective treatment options.
Which are the top treatments for delayed sleep phase syndrome being explored in clinical trials?
When it comes to exploring new treatments for delayed sleep phase syndrome in clinical trials, several options show promise. Lemborexant has emerged as a frontrunner, with one active trial dedicated to this condition since its first listing in 2022. Another intriguing avenue is studying the effects of monitoring sleep, mood, and substance use on managing delayed sleep phase syndrome, with one ongoing trial investigating this approach from 2021 onwards. Additionally, tasimelteon enters the spotlight as a potential treatment option for this disorder through one active trial that commenced in 2020. These innovative avenues offer hope for individuals struggling with delayed sleep phase syndrome and pave the way towards improved management strategies.
What are the most recent clinical trials for delayed sleep phase syndrome?
Recent clinical trials for delayed sleep phase syndrome have explored the efficacy of different medications in managing this condition. Lemborexant, a medication currently in Phase 4, has shown potential as a treatment option for individuals struggling with delayed sleep phase syndrome. Similarly, tasimelteon has been investigated through multiple phases of clinical trials and has displayed promising results in addressing the symptoms associated with this disorder. As research continues to progress, these recent studies offer hope for improved management and better quality of life for those affected by delayed sleep phase syndrome.
What delayed sleep phase syndrome clinical trials were recently completed?
Recently completed clinical trials have made significant progress in addressing delayed sleep phase syndrome, a disorder that disrupts the natural sleep-wake cycle. These pioneering studies have shed light on potential treatments and brought hope to those affected by this condition.